|
Market Closed -
Hong Kong S.E.
04:08:32 2026-09-18 EDT
|
5-day change | 1st Jan Change | ||
| 8.125 HKD | -2.11% |
|
+2.20% | -5.52% |
Company Valuation: China Shineway Pharmaceutical Group Limited
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 4,240 | 5,072 | 4,985 | 6,850 | 5,838 | 5,243 | - | - |
| Change | - | 19.61% | -1.71% | 37.41% | -14.78% | -10.19% | - | - |
| Enterprise Value (EV) | 49.32 | 25.13 | 4,985 | 6,850 | 5,838 | 5,243 | 5,243 | 5,243 |
| Change | - | -49.04% | 19,734.74% | 37.41% | -14.78% | -10.19% | 0% | 0% |
| P/E | 7.59x | 6.99x | 5.16x | 8.17x | 6.13x | 6.94x | 6.46x | 6.07x |
| PBR | 0.72x | 0.79x | 0.71x | - | 0.72x | 0.66x | - | - |
| PEG | - | 0.2x | 0.2x | -0.6x | 0.5x | -0.3x | 0.87x | 0.94x |
| Capitalization / Revenue | 1.32x | 1.28x | 1.1x | 1.81x | 1.86x | 2.24x | 2.23x | 2.16x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 2.24x | 2.23x | 2.16x |
| EV / EBITDA | 0x | 0x | 0x | 0x | 0x | 6.45x | 6.06x | 5.75x |
| EV / EBIT | 0x | 0x | 0x | 0x | 0x | 6.45x | 6.06x | 5.75x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | 0.39 | 0.32 | 0.42 | 0.54 | - | - | - | - |
| Rate of return | 6.95% | 4.77% | 6.36% | 5.95% | - | - | - | - |
| EPS 2 | 0.74 | 0.96 | 1.28 | 1.11 | 1.26 | 1 | 1.074 | 1.143 |
| Distribution rate | 52.7% | 33.3% | 32.8% | 48.6% | - | - | - | - |
| Net sales 1 | 3,224 | 3,951 | 4,517 | 3,778 | 3,135 | 2,344 | 2,347 | 2,427 |
| EBITDA 1 | 826 | 1,022 | 1,316 | 1,306 | 1,047 | 813 | 865 | 911 |
| EBIT 1 | 643.6 | 835.8 | 1,139 | 1,025 | 896 | 813 | 865 | 911 |
| Net income 1 | 556.7 | 722.8 | 969.5 | 840.1 | 949.9 | 755 | 811 | 864 |
| Net Debt | -4,191 | -5,046 | - | - | - | - | - | - |
| Reference price 2 | 5.613 | 6.714 | 6.599 | 9.068 | 7.728 | 6.940 | 6.940 | 6.940 |
| Nbr of stocks (in thousands) | 755,400 | 755,400 | 755,400 | 755,400 | 755,400 | 755,400 | - | - |
| Announcement Date | 3/29/22 | 3/30/23 | 3/28/24 | 3/28/25 | 3/27/26 | - | - | - |
1CNY in Million2CNY
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
| 6.94x | - | - | - | 782M | ||
| 33.9x | 6.35x | 22.04x | 0.93% | 45.94B | ||
| 15.9x | 1.97x | 8.74x | 1.7% | 37.22B | ||
| 27.81x | 3.97x | 16.44x | 0.58% | 12.06B | ||
| 27.15x | 3.29x | 17.06x | 0.93% | 11.74B | ||
| 18.58x | 3.37x | 11.75x | 3.79% | 9.03B | ||
| 9.44x | 2.18x | 5.65x | 4.7% | 7.36B | ||
| 29.77x | 3.9x | 18.12x | 0.16% | 7.2B | ||
| 15.18x | 2.01x | 6.67x | 3.28% | 7.15B | ||
| Average | 20.52x | 3.38x | 13.31x | 2.01% | 15.39B | |
| Weighted average by Cap. | 24.33x | 3.93x | 14.98x | 1.58% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 2877 Stock
- Valuation China Shineway Pharmaceutical Group Limited
Select your edition
All financial news and data tailored to specific country editions
















